Clinical Outcome of Prostate Cancer Patients with Germline DNA Repair Mutations: Retrospective Analysis from an International Study

Mateo, J; Cheng, HH; Beltran, H; Dolling, D; Xu, W; Pritchard, CC; Mossop, H; Rescigno, P; Perez-Lopez, R; Sailer, V; Kolinsky, M; Balasopoulou, A; Bertan, C; Nanus, DM; Tagawa, ST; Thorne, H; Montgomery, B; Carreira, S; Sandhu, S; Rubin, MA; Nelson,

de Bono, JS (reprint author), Royal Marsden NHS Fdn Trust, Drug Dev Unit, Inst Canc Res, Div Clin Studies, Downs Rd, Sutton SM2 5PT, Surrey, England.

EUROPEAN UROLOGY, 2018; 73 (5): 687

Abstract

Background: Germline DNA damage repair gene mutation (gDDRm) is found in >10% of metastatic prostate cancer (mPC). Their prognostic and predictive ......

Full Text Link